Generic Suboxone products enter U.S. market

At least three companies have launched in the U.S. generic versions of opioid dependence drug Suboxone buprenorphine/naloxone sublingual film from Indivior plc (LSE:INDV).

The generic Suboxone manufacturers include Alvogen Inc. (Pinebrook, N.J.), the Sandoz unit of Novartis AG (NYSE:NVS; SIX:NOVN) and Dr. Reddy's Laboratories Ltd. (NYSE:RDY). The launches follow a Feb. 18 decision by the U.S. Supreme Court denying Indivior's motion to restrict Dr. Reddy's from launching its generic to the U.S. market...